NCT00016302 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Status COMPLETED Phase NA
NCT00016016 Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Acute Leukemia Status COMPLETED Phase PHASE1/PHASE2
NCT00015951 Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers Status COMPLETED Phase PHASE2
NCT00015873 Comparison of Different Combination Chemotherapy Regimens in Treating Infants With Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE3
NCT00015834 STI571 Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia Status COMPLETED Phase PHASE1/PHASE2
NCT00014495 Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00012051 Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE3
NCT00007852 Rituximab & Combination Chemotherapy Followed by Transplantation in Relapsed or Refractory Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE2
NCT00006747 Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma Status COMPLETED Phase PHASE2
NCT00006695 Monoclonal Antibody Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplant in Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE2
NCT00006455 Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma (ALCL 99) Status COMPLETED Phase PHASE3
NCT00006367 Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis Status COMPLETED Phase PHASE2
NCT00006363 Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia Status COMPLETED Phase PHASE3
NCT00006343 STI571 Compared With Interferon Alfa Plus Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia Status COMPLETED Phase PHASE3
NCT00006122 Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia Status COMPLETED Phase PHASE2
NCT00006045 Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia Status UNKNOWN Phase PHASE3
NCT00005998 Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease Status WITHDRAWN Phase PHASE2
NCT00005985 Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE2
NCT00005977 Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia Status COMPLETED Phase PHASE3
NCT00005962 Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia Status COMPLETED Phase PHASE2